ABSTRACT A type C virus was isolated from C3H/iOTl/2 mouse cells in culture after activation with iododeoxyuridine. This virus was poorly infectious for mouse cells and did not cause tumors upon inoculation into newborn NIH Swiss mice. Variants with increased infectivity for mouse cells were then derived both in vivo and in vitro by selecting for variants able to grow to high titers. The highly infectious variants were found to induce mouse fibroblasts to grow in soft agar. When the viruses were inoculated into newborn NIH Swiss mice, 100% of the animals died of leukemia within 4 months. Solid tumors developed at the injection site. Both mouse-tropic and dualtropic viruses were isolated from the leukemic mice and plaque purified. The first group of viruses produced large syncytial plaques on rat XC cells and did not grow in mink cells. The viruses of the other group replicated well in both mouse and mink cells, producing morphologic changes similar to transformation but not XC syncytia; they, therefore, are members of the newly described MCF class of mouse type C viruses. Isolates from either group were highly leukemogenic on retesting, the mean latent period being 67 days for a mouse-tropic virus and 105 days for one of the dual-tropic viruses. The results led to the conclusion that the better a mouse type C virus grows in cell culture the more effective it is as a leukemogen. Further, it is possible to start with a weakly infectious, nonleukemogenic virus and to convert it to a rapidly replicating, highly leukemogenic virus bypassage either in cell culture or in the animal. The availability of a defined series of viruses from a low-leukemia mouse strain that differ greatly in their biologic properties should facilitate studies of the molecular basis for the acquisition of type C virus oncogenicity.
sion that the better a mouse type C virus grows in cell culture the more effective it is as a leukemogen. Further, it is possible to start with a weakly infectious, nonleukemogenic virus and to convert it to a rapidly replicating, highly leukemogenic virus bypassage either in cell culture or in the animal. The availability of a defined series of viruses from a low-leukemia mouse strain that differ greatly in their biologic properties should facilitate studies of the molecular basis for the acquisition of type C virus oncogenicity.
Highly oncogenic type C viruses that produce leukemias or sarcomas in infected animals generally have had a long passage history and, in some cases, their origins are difficult to trace. The development of oncogenic viruses from low or nononcogenic viruses through a defined passage history should facilitate an understanding of the mechanisms by which transforming type C viruses are generated and allow the identification of virus expression associated with induction of neoplasia.
In the present studies, a poorly infectious, XC test negative, N-tropic nontransforming virus isolated from cells of a lowleukemic mouse strain was used to derive rapidly replicating transforming variants under defined conditions, both in vivo and in vitro. The replication of the parent endogenous mouse-tropic virus, isolated from the C3H/iOTi/2 cell line, is blocked at a level prior to the assembly of complete infectious virus. The new viruses replicate efficiently in cell culture and induce lymphocytic leukemia at high incidence and with a short latency period following inoculation of newborn NIH Swiss mice. Certain clones of these new viruses also transform mouse fibroblasts, NIH/3T3 and C3H/iOTi/2 (1i and mink epithelial cells in culture.
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MATERIALS AND METHODS Animals. NIH Swiss mice were obtained from the National Institutes of Health colony. Newborn mice were injected intraperitoneally with freshly cloned virus grown in C3H/1OTI/2 CL8 (1) or SC-1 (2) cells; 2000-5000 infectious units (see below) were used per mouse. The animals were weaned at 4 weeks and portions of the tails were removed at monthly intervals for determination of the virus status of the injected animals.
Cells. All cell lines were maintained in Eagle's minimum essential medium (MEM) with 10% heat-inactivated fetal calf serum. The origin and characteristics of the cell lines used for virus growth and virus assays have been described (3, 4) . The C3H/iOT1/2 CL8 line was developed from a C3H/Heston mouse embryo (1) . This strain has a low "spontaneous" leukemia incidence. The 1OT1/2 line has been widely used for chemical carcinogenesis studies and has been shown to have endogenous type C viruses that can be activated (3). Ecotropic virus was assayed using the feral mouse cells SC-1 (4) or NIH/ 3T3 (5) cells and xenotropic virus was titered on the mink lung cell line Mv-i-Lu (6) . Viral Assays. Three types of assays were used: the XC test (7), the DNA polymerase induction assay (4) , and the fluorescent-focus induction test (4) . For infection, cells were seeded at 1 X 105 per 60-mm dish. One day after seeding, the cells were treated with Polybrene (20 g/ml) for 1 hr and then infected with 0.2 ml of virus suspension. After incubation for 2 hr. the virus inoculum was removed and 5 ml of complete medium was added. Twenty-four hours later, cultures were processed for indirect immunofluorescence with fixed cells as previously described (4) . Culture fluids were collected at early confluency for determination of particle-bound DNA polymerase activity (4) Fig. 1 , these cultures produce a replication-deficient (R-) XC test negative (XC-) virus that spreads slowly through the culture so that after six to eight subcultures (in phase III) over 90% of the cells are producing virus (3). The virus-producing culture was single cell cloned. One particular high-producer clone (clone A2) was the source of the R-XCnontransforming, nonleukemogenic (NL) virus used in subsequent studies.
Derivation of High-Leukemia MuLVs in Cell Culture. Fig.  2 summarizes the two routes used to derive highly infectious MuLV. The first method involved selection for rapid replicating ability in transformed mouse cells in culture. The second method involved virus replication in thymus tissue in vivo.
The wild mouse cell line, SC-1, was infected with the R-XCvirus. The virus produced was serially transferred 8 to 12 times, yielding a virus able to grow to high titers in a variety of "Ntype" mouse cells, including C3H/1OT1/2 and NIH/3T3 (2) . Similarly altered viruses have been produced by serially transferring the R-XC-virus in methylcholanthrene-transformed C3H/1OT1/2 cells. The conversion to high-titer growth occurs in two discrete steps: the first leading from R-XC-to R+XC+ virus (4) , and the second from R+XC+ to R++XC+ (Fig.  3 ). The resulting virus was cloned from large XC plaques and grew to very high titers on susceptible mouse cell lines. The pattern of conversion shown in Fig. 3 with SC-1 cells is similar to that with methylcholanthrene-transformed C3H/1OT1/2 cells. The first conversion was observed after two to four virus subcultures and the second conversion occurred after three to eight additional transfers. Concomitant with, or shortly after, the first and second conversions, a xenotropic virus was transiently released; its time of appearance is indicated by the arrows in Fig. 3 .
Derivation of High-Leukemia MuLVs In Vivo. MuLV was isolated from the thymus of NIH Swiss mice inoculated as newborns with either R-XC-or R+XC+ virus (see Fig. 2 ). The virus studied in detail was from the thymus of a 2-month-old symptom-free NIH Swiss mouse inoculated at birth with the poorly replicating R-XC-isolate. Mouse-tropic, xenotropic, and dual-tropic viruses were isolated from leukemic tissues. Representatives of each of the three host range types were grown in mouse and/or mink cells (Fig. 2) The final titers produced were 103-104 infectious units.
(ii) Infectious, XC+ mouse-tropic virus, the prototype being the R+XC+SL virus derived from R-XC-NL in vitro. The rate of spread, as well as the lag period after infection and the final titers produced, are similar to the values obtained in the first group. N-tropic AKR MuLV were isolated from tail extracts of young adult mice (12) . (iii) The in vitro and in vivo derived R++XC+RL mouse-tropic and R++XC-RL dual-tropic variants, which have a very high spreading rate and achieve final titers 102-103 times greater than those obtained with the R+XC+SL viruses. Growth of Virus-Infected Cells in Soft Agar. Several observations have been made which show that the R++ viruses affect the cell growth properties. The dual-tropic viruses (R++XC-RL) form cytotoxic plaques on mink cells. Foci of altered growth are also seen, although overgrowth of the cell monolayer is less pronounced than that caused by laboratory strains of sarcoma viruses. Morphologically altered cells are often seen at the edges of cytotoxic plaques. Fresh isolates of uncloned R++XC+RL virus from the leukemic animal showed plaque formation in NIH/3T3 cells as a linear function of dose. These plaques contained syncytial cells, developing 2-3 days after infection, associated with areas of overgrowth and rounding of cells. Focal areas made up of cells with the latter characteristics were also seen in the absence of direct plaque formation. Upon continued passage of the virus the cytotoxic effect diminished and the ability to induce focal areas was lost. Similar morphological alterations have been observed with pathogenic variants of avian leukosis viruses (13).
The experiment described in Fig. 5 was performed to quantitate the transforming ability of these rapidly leukemogenic variants. C3H/1OT1/2 CL8 cells were infected and seeded into soft agar. Colony growth was monitored for 3 weeks. Infection with cloned viruses of the R+XC sl or R++XC+RL group resulted in an increase in the fraction of cells growing in agar, and in the size of the colonies (Fig. 5) . Infection with DISCUSSION This report describes the isolation of highly leukemogenic type C viruses from poorly infectious, nononcogenic, endogenous mouse type C viruses. Repeated transfer of virus in transformed mouse fibroblast cell lines led to formation of high-titered, rapidly leukemogenic mouse-tropic MuLV, activation of xenotropic MuLV, and the appearance of viruses with a dual host range. In the animal the process was also accompanied by activation of xenotropic MuLV. Inoculation of the high-replicating mouse-tropic MuLV into newborn NIH Swiss mice led to the development of lymphocytic leukemia within 4 months in 100% of the animals. A comparison of the leukemogenicity of the three different host range classes of viruses showed that the R++XC+RL mouse-tropic viruses were the most pathogenic isolates, followed by the dual-tropic MuLV.
The most characteristic properties common to the highly oncogenic variants are their rapid and high-titer growth in vivo and in vitro and their ability to induce growth of fibroblasts in soft agar. (10) . The viruses contain components that grow in mouse and mink cells and form foci on mink cells (11) . They are found in preleukemic thymuses from high-leukemic strains and, therefore, are implicated in disease development (10) . Evidence has been presented that they form as a result of recombination between mouse-tropic and xenotropic endogenous viruses (10, 11) . The dual-tropic, mink cell-transforming, XC-viruses described here have many properties similar to those of the MCF isolates. They can, however, be obtained entirely from tissue culture cells of low-leukemia mouse strains. The dual-tropic viruses described here have a viral envelope glycoprotein, gp7O, very much like the MCF viruses by serologic tests, but the properties of the small internal viral proteins (p12 and p15) are distinctly different. Dual-tropic plaque isolates differ from one another and from the MCF viruses in the immunologic properties of their small proteins (unpublished experiments).
The observations described in this report suggest a strategy for the isolation of new rapidly transforming viruses. The first step is the adaptation of a given virus to high-titer growth. This leads to the emergence of virus with some, albeit limited, potential for fibroblast transformation, inducing morphological alterations and growth in soft agar in vitro. Because agar colonies usually do not grow progressively, the transforming effect of these viruses may initially be more akin to the "abortive transformation" effect described for the DNA tumor viruses (16) . Through further selection of virus from such focal areas of altered growth, more efficiently transforming viruses may be isolated and characterized.
